The Cigna Group (NYSE:CI) Shares Acquired by Strategic Blueprint LLC

Strategic Blueprint LLC increased its holdings in shares of The Cigna Group (NYSE:CIFree Report) by 9.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 805 shares of the health services provider’s stock after acquiring an additional 72 shares during the period. Strategic Blueprint LLC’s holdings in The Cigna Group were worth $222,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CI. ORG Wealth Partners LLC acquired a new stake in The Cigna Group in the fourth quarter valued at $34,000. Ulland Investment Advisors LLC increased its holdings in The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after acquiring an additional 100 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in The Cigna Group during the third quarter worth about $37,000. Harbor Capital Advisors Inc. purchased a new stake in shares of The Cigna Group in the third quarter valued at about $45,000. Finally, Intact Investment Management Inc. acquired a new stake in shares of The Cigna Group in the third quarter valued at approximately $69,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Stock Performance

NYSE CI opened at $293.99 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The firm has a market capitalization of $81.77 billion, a P/E ratio of 27.73, a P/E/G ratio of 0.82 and a beta of 0.54. The business’s 50-day simple moving average is $294.40 and its 200-day simple moving average is $324.43.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. During the same quarter last year, the firm earned $6.79 EPS. Equities analysts predict that The Cigna Group will post 28.5 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be issued a $1.51 dividend. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 2.05%. The ex-dividend date of this dividend is Wednesday, March 5th. The Cigna Group’s dividend payout ratio is currently 52.83%.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on CI shares. Deutsche Bank Aktiengesellschaft cut their price objective on The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research report on Monday, November 4th. Oppenheimer decreased their price objective on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating on the stock in a research note on Friday. Royal Bank of Canada cut their target price on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. StockNews.com cut shares of The Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Truist Financial cut their price objective on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $380.27.

Check Out Our Latest Research Report on CI

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.